Overall, the results obtained by flow cytometry, immunofluorescence/immunohistochemistry, and bioinformatics show that a CD8+ CD103+ CD69+ TRM T lymphocyte population is significantly increased amongst GBM TILs. This evidence concerns the gene CD8A and glioblastoma.